{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:22:51Z","timestamp":1794082971040,"version":"4.8.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04113-9","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T01:28:15Z","timestamp":1746494895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predictive factors for adherence to intravitreal anti-vascular endothelial growth factor therapy in Palestinian patients with diabetic retinopathy, retinal vein occlusion, and age-related macular degeneration: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Hamza","family":"Abualhasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ithar M","family":"Beshtawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othman","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salem","family":"Hantoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"issue":"10","key":"4113_CR1","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.4103\/ijo.IJO_1866_19","volume":"68","author":"A Kelkar","year":"2020","unstructured":"Kelkar A, Webers C, Shetty R, Kelkar J, Labhsetwar N, Pandit A, et al. Factors affecting compliance to intravitreal anti-vascular endothelial growth factor therapy in Indian patients with retinal vein occlusion, age-related macular degeneration, and diabetic macular edema. Indian J Ophthalmol. 2020;68(10):2143. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7728040\/. [cited 2023 Jul 24].","journal-title":"Indian J Ophthalmol."},{"issue":"10","key":"4113_CR2","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.clinthera.2021.08.011","volume":"43","author":"NM Schultz","year":"2021","unstructured":"Schultz NM, Bhardwaj S, Barclay C, Gaspar L, Schwartz J. Global Burden of Dry Age-Related Macular Degeneration: A Targeted Literature Review. Clin Ther. 2021;43(10):1792\u2013818.\u00a0Available from:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/34548176\/. [cited 2023 Dec 11].","journal-title":"Clin Ther."},{"issue":"1","key":"4113_CR3","doi-asserted-by":"publisher","first-page":"010427","DOI":"10.7189\/jogh.09.010427","volume":"9","author":"P Song","year":"2019","unstructured":"Song P, Xu Y, Zha M, Zhang Y, Rudan I. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health. 2019;9(1):010427.\u00a0Available from:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/31131101\/. [cited 2023 Dec 11].","journal-title":"J Glob Health."},{"key":"4113_CR4","first-page":"157","volume":"9","author":"RL Thomas","year":"2019","unstructured":"Thomas RL, Halim S, Gurudas S, Sivaprasad S, Owens DR. IDF Diabetes Atlas: A review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018. Diabetes Res Clin Pract. 2019;9:157.\u00a0Available from:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/31733978\/. [cited 2023 Dec 11].","journal-title":"Diabetes Res Clin Pract."},{"issue":"2","key":"4113_CR5","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s40200-020-00575-4","volume":"19","author":"T Yahya","year":"2020","unstructured":"Yahya T, Nazzal Z, Abdul-Hadi AR, Belkebir S, Hamarshih M, Fuqaha A, et al. Diabetic retinopathy screening barriers among Palestinian primary health care patients: a qualitative study. J Diabetes Metab Disord. 2020;19(2):875 Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7843686\/. [cited 2023 Dec 11].","journal-title":"J Diabetes Metab Disord."},{"key":"4113_CR6","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/S0140-6736(22)01154-0","volume":"399","author":"N Mikki","year":"2022","unstructured":"Mikki N, Mactaggart I. The prevalence of diabetic retinopathy in the occupied Palestinian territories: a national cross-sectional study. Lancet. 2022;399:S19.\u00a0Available from:\u00a0https:\/\/www.thelancet.com\/action\/showFullText?pii=S0140673622011540. [cited 2025 Mar 31].","journal-title":"Lancet."},{"issue":"3","key":"4113_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1586\/eop.13.17","volume":"8","author":"M Al-Shabrawey","year":"2013","unstructured":"Al-Shabrawey M, Elsherbiny M, Nussbaum J, Othman A, Megyerdi S, Tawfik A. Targeting Neovascularization in Ischemic Retinopathy: Recent Advances. Expert Rev Ophthalmol. 2013;8(3):267 Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4295791\/. [cited 2023 Jul 24].","journal-title":"Expert Rev Ophthalmol."},{"issue":"6","key":"4113_CR8","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/s41433-018-0021-7","volume":"32","author":"S Fogli","year":"2018","unstructured":"Fogli S, Del Re M, Rofi E, Posarelli C, Figus M, Danesi R. Clinical pharmacology of intravitreal anti-VEGF drugs. Eye. 2018;32(6):1010 Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5997665\/. [cited 2023 Jul 24].","journal-title":"Eye."},{"key":"4113_CR9","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.2147\/DDDT.S295223","volume":"15","author":"RM Hussain","year":"2021","unstructured":"Hussain RM, Shaukat BA, Ciulla LM, Berrocal AM, Sridhar J. Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration. Drug Des Devel Ther. 2021;15:2653 Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8232378\/. [cited 2022 Dec 20].","journal-title":"Drug Des Devel Ther."},{"issue":"2","key":"4113_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11739-019-02253-7","volume":"15","author":"M Porta","year":"2020","unstructured":"Porta M, Striglia E. Intravitreal anti-VEGF agents and cardiovascular risk. Intern Emerg Med. 2020;15(2):199\u2013210.\u00a0Available from:\u00a0https:\/\/link.springer.com\/article\/10.1007\/s11739-019-02253-7. [cited 2022 Dec 20].","journal-title":"Intern Emerg Med."},{"key":"4113_CR11","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2147\/PPA.S347713","volume":"16","author":"A Giocanti-Aur\u00e9gan","year":"2022","unstructured":"Giocanti-Aur\u00e9gan A, Garc\u00eda-Layana A, Peto T, Gentile B, Chi GC, Mirt M, et al. Drivers of and Barriers to Adherence to Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treatment Management Plans: A Multi-National Qualitative Study. Patient Prefer Adherence. 2022;16:587\u2013604.\u00a0Available from:\u00a0https:\/\/www.dovepress.com\/drivers-of-and-barriers-to-adherence-to-neovascular-age-related-macula-peer-reviewed-fulltext-article-PPA. [cited 2023 Jan 13].","journal-title":"Patient Prefer Adherence."},{"issue":"1","key":"4113_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-023-02261-x","volume":"12","author":"H Shahzad","year":"2023","unstructured":"Shahzad H, Mahmood S, McGee S, Hubbard J, Haque S, Paudyal V, et al. Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis. Syst Rev. 2023;12(1):1\u201314.\u00a0Available from:\u00a0https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-023-02261-x. [cited 2025 Mar 26].","journal-title":"Syst Rev."},{"issue":"1","key":"4113_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13643-023-02261-x","volume":"12","author":"H Shahzad","year":"2023","unstructured":"Shahzad H, Mahmood S, McGee S, Hubbard J, Haque S, Paudyal V, et al. Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis. Syst Rev. 2023;12(1):92.\u00a0Available from:\u00a0https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10237080\/. [cited 2025 Apr 22].","journal-title":"Syst Rev."},{"issue":"4","key":"4113_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4274\/tjo.28003","volume":"47","author":"O Polat","year":"2017","unstructured":"Polat O, \u0130nan S, \u00d6zcan S, Do\u011fan M, K\u00fcsbeci T, Yava\u015f GF, et al. Factors Affecting Compliance to Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Age-Related Macular Degeneration. Turkish J Ophthalmol. 2017;47(4):205 Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5563548\/. [cited 2024 Jan 18].","journal-title":"Turkish J Ophthalmol."},{"issue":"3","key":"4113_CR15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/IAE.0b013e31827b6324","volume":"33","author":"SY Cohen","year":"2013","unstructured":"Cohen SY, Mimoun G, Oubraham H, Zourdani A, Malbrel C, Quer\u00e9 S, et al. Changes in visual acuity in patients with wet age-related macular degeneration treated with intravitreal ranibizumab in daily clinical practice: the LUMIERE study. Retina. 2013;33(3):474\u201381.\u00a0Available from:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/23266880\/. [cited 2025 Apr 23].","journal-title":"Retina."},{"key":"4113_CR16","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2147\/OPTH.S248661","volume":"14","author":"NE Abu-Yaghi","year":"2020","unstructured":"Abu-Yaghi NE, Abed AM, Khlaifat DF, Nawaiseh MB, Emoush LO, Alhajjaj HZ, et al. Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients. Clin Ophthalmol. 2020;14:921\u20139.\u00a0Available from:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/32273676\/. [cited 2025 Apr 23].","journal-title":"Clin Ophthalmol."},{"issue":"5","key":"4113_CR17","doi-asserted-by":"publisher","first-page":"e022031","DOI":"10.1136\/bmjopen-2018-022031","volume":"9","author":"B Pham","year":"2019","unstructured":"Pham B, Thomas SM, Lillie E, Lee T, Hamid J, Richter T, et al. Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis. BMJ Open. 2019;9(5):e022031.\u00a0Available from:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/31142516\/. [cited 2023 Dec 16].","journal-title":"BMJ Open."},{"key":"4113_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/OPTH.S151611","volume":"12","author":"C Ehlken","year":"2017","unstructured":"Ehlken C, Helms M, B\u00f6hringer D, Agostini HT, Stahl A. Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients. Clin Ophthalmol. 2017;12:13\u201320.\u00a0Available from:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/29339917\/. [cited 2023 Dec 16].","journal-title":"Clin Ophthalmol."},{"issue":"12","key":"4113_CR19","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1097\/IAE.0000000000001892","volume":"38","author":"M Weiss","year":"2018","unstructured":"Weiss M, Sim DA, Herold T, Schumann RG, Liegl R, Kern C, et al. COMPLIANCE AND ADHERENCE OF PATIENTS WITH DIABETIC MACULAR EDEMA TO INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN DAILY PRACTICE. Retina. 2018;38(12):2293\u2013300.\u00a0Available from:\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/29068914\/. [cited 2023 Dec 16].","journal-title":"Retina."},{"issue":"4","key":"4113_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4274\/tjo.28003","volume":"47","author":"O Polat","year":"2017","unstructured":"Polat O, \u0130nan S, \u00d6zcan S, Do\u011fan M, K\u00fcsbeci T, Yava\u015f GF, et al. Factors Affecting Compliance to Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Age-Related Macular Degeneration. Turkish J Ophthalmol. 2017;47(4):205 Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5563548\/. [cited 2023 Dec 16].","journal-title":"Turkish J Ophthalmol."},{"issue":"9","key":"4113_CR21","doi-asserted-by":"publisher","first-page":"e0003613","DOI":"10.1371\/journal.pgph.0003613","volume":"4","author":"N Mikki","year":"2024","unstructured":"Mikki N, McCormick I, Mactaggart I. Prevalence of vision impairment, diabetic retinopathy and disability in adults 50+ in the occupied Palestinian territories. PLOS Glob Public Heal. 2024;4(9):e0003613.\u00a0Available from:\u00a0https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11426490\/. [cited 2025 Mar 29].","journal-title":"PLOS Glob Public Heal."}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04113-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T01:28:16Z","timestamp":1746494896000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04113-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4113"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04113-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4656531\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects. This study was performed under the guidelines of the Declaration of Helsinki and was approved by the institutional review board of An-Najah National University.Your study title is \u201cPredictive Factors for Adherence to Intravitreal anti-vascular Endothelial Growth Factor Therapy in Palestinian Patients with diabetic retinopathy, Retinal Vein Occlusion, and age-related macular Degeneration: A retrospective cohort study,\u201d was reviewed by the An-Najah National University IRB committee and was approved on 3rd Sept 2023 (Med. Sept. 2023\/5).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for publication was obtained from every individual whose data are included in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"268"}}